Zhang A - Search Results

1

Real-world survival and economic burden among patients with locally advanced or metastatic urothelial carcinoma in the United States.

Chen RC, Fuldeore R, Greatsinger A, Hepp Z, Liu Q, Wright P, Xie B, Yang H, Young C, Zhang A, Mucha L. Chen RC, et al. Among authors: zhang a. Urol Oncol. 2024 Dec 14:S1078-1439(24)00744-0. doi: 10.1016/j.urolonc.2024.11.010. Online ahead of print. Urol Oncol. 2024. PMID: 39675951 Free article.

2

Real-world overall survival with abiraterone acetate versus enzalutamide in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer.

George DJ, Ramaswamy K, Yang H, Liu Q, Zhang A, Greatsinger A, Ivanova J, Thompson B, Emir B, Hong A, Freedland SJ. George DJ, et al. Among authors: zhang a. Prostate Cancer Prostatic Dis. 2024 Dec;27(4):756-764. doi: 10.1038/s41391-024-00816-0. Epub 2024 Mar 27. Prostate Cancer Prostatic Dis. 2024. PMID: 38538879 Free PMC article.

3

Frequency and economic burden of exacerbations in inhaled corticosteroid/long-acting beta-agonist-treated patients with asthma: A retrospective US claims study.

Duh MS, Roberts MH, Rothnie KJ, Cheng WY, Thompson-Leduc P, Zhang S, Czira A, Slade D, Greatsinger A, Zhang A, Mapel D. Duh MS, et al. Among authors: zhang s, zhang a. Respir Med. 2024 May;226:107629. doi: 10.1016/j.rmed.2024.107629. Epub 2024 Apr 7. Respir Med. 2024. PMID: 38593885

4

Cost-Effectiveness Analysis of Pembrolizumab as an Adjuvant Treatment of Resected Stage IIB or IIC Melanoma in the United States.

Zhang S, Bensimon AG, Xu R, Jiang R, Greatsinger A, Zhang A, Fukunaga-Kalabis M, Krepler C. Zhang S, et al. Among authors: zhang a. Adv Ther. 2023 Jul;40(7):3038-3055. doi: 10.1007/s12325-023-02525-x. Epub 2023 May 16. Adv Ther. 2023. PMID: 37191852 Free PMC article.

5

Development and validation of a claims-based algorithm to identify moderate exacerbations in patients with asthma treated in the US.

Roberts MH, Duh MS, Rothnie KJ, Zhang S, Czira A, Slade D, Cheng WY, Thompson-Leduc P, Greatsinger A, Zhang A, Mapel D. Roberts MH, et al. Among authors: zhang s, zhang a. Respir Med. 2024 May;226:107630. doi: 10.1016/j.rmed.2024.107630. Epub 2024 Apr 7. Respir Med. 2024. PMID: 38593886

6

Treatment Patterns and Clinical Outcomes Among Patients With Metastatic Prostate Cancer Harboring Homologous Recombination Repair Mutations.

Bobbili PJ, Ivanova J, Solit DB, Mettu NB, McCall SJ, Dhawan M, DerSarkissian M, Arondekar B, Chang J, Niyazov A, Lee J, Huq R, Green M, Turski M, Lam P, Muthukumar A, Guo T, Mohan M, Zhang A, Duh MS, Oh WK. Bobbili PJ, et al. Among authors: zhang a. Clin Genitourin Cancer. 2024 Jun;22(3):102080. doi: 10.1016/j.clgc.2024.102080. Epub 2024 Mar 23. Clin Genitourin Cancer. 2024. PMID: 38653037 Free article.

7

Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19: Evidence from the US National COVID Cohort Collaborative (N3C).

Bell CF, Bobbili P, Desai R, Gibbons DC, Drysdale M, DerSarkissian M, Patel V, Birch HJ, Lloyd EJ, Zhang A, Duh MS; N3C consortium. Bell CF, et al. Among authors: zhang a. Clin Drug Investig. 2024 Mar;44(3):183-198. doi: 10.1007/s40261-024-01344-4. Epub 2024 Feb 20. Clin Drug Investig. 2024. PMID: 38379107 Free PMC article.

8

Disease progression rates in ambulatory Duchenne muscular dystrophy by steroid type, patient age and functional status.

McDonald CM, Marden JR, Shieh PB, Wong BL, Lane H, Zhang A, Nguyen H, Frean M, Trifillis P, Koladicz K, Signorovitch J. McDonald CM, et al. Among authors: zhang a. J Comp Eff Res. 2023 Apr;12(4):e220190. doi: 10.57264/cer-2022-0190. Epub 2023 Feb 7. J Comp Eff Res. 2023. PMID: 36749302 Free PMC article. Clinical Trial.

9

Exosomal circ_0006896 promotes AML progression via interaction with HDAC1 and restriction of antitumor immunity.

Can C, Yang X, Jia H, Wu H, Guo X, Wei Y, Jia Z, Liu W, Zhang A, He N, Zhang H, Ma D. Can C, et al. Among authors: zhang a. Mol Cancer. 2025 Jan 6;24(1):4. doi: 10.1186/s12943-024-02203-8. Mol Cancer. 2025. PMID: 39762891

10

A universal gene expression signature-based strategy for the high-throughput discovery of anti-inflammatory drugs.

Feng J, Dang H, Zhang X, Huang W, Ma C, Zhang A, Hao M, Xie L. Feng J, et al. Among authors: zhang a. Inflamm Res. 2025 Jan 7;74(1):2. doi: 10.1007/s00011-024-01968-4. Inflamm Res. 2025. PMID: 39762416

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,663 results

Search Page

Filters